Phys Vivas · oncological
Cancer Cachexia AND Nutritional Support — Viva Defence
DCE viva defence for Cancer Cachexia AND Nutritional Support.
On this page & tools
Target exams
Cancer Cachexia AND Nutritional Support Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Cancer Cachexia AND Nutritional Support. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
Short case
Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]
References
- [1]Liu TK, Noble D, Stares M, Phillips I Identifying markers of cachexia and nutritional deficit on radical radiotherapy outcomes in lung and head and neck cancer Curr Opin Support Palliat Care, 2026.PMID 42421369
- [2]Petersen E, Sheldon J, Torgerson H, Kirschenbaum M, et al. The impact of cachexia and sarcopenia in bladder cancer Curr Opin Support Palliat Care, 2026.PMID 42417054
- [3]Monnery D, Collins J, Droney J Practical prescribing in cancer cachexia Curr Opin Support Palliat Care, 2026.PMID 42411339
- [4]Shen S, Zhou K, Wu M, Liu D, et al. Feeding intelligence: comparative evaluation of ChatGPT and clinical guidelines for nutritional management in head and neck cancer J Transl Med, 2025.PMID 41272713
- [5]Muscaritoli M, Molfino A, Orlando S, Tambaro F Advancements of investigational agents for cancer cachexia: what clinical progress have we seen in the last 5 years? Expert Opin Investig Drugs, 2025.PMID 41222020
- [6]Hustad KS, Kaasa S, Laird BJA Integrated nutritional care in cancer; about time? Curr Opin Support Palliat Care, 2025.PMID 40689650
- [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922